The initial comprehensive analysis of overall CD surface marker expression (see Fig. 1, see Table 1) revealed high expression levels of molecules generally involved in tumor invasiveness (CD29, CD44, CD57, CD184) and cell survival (integrins, CD220, CD221) as well as the presence of cancer stem cell-associated markers (CD15, CD24, CD44). The gene discussed is CD24; the disease is cancer.